tashima-tarsh/oncologist
v1.0.0MIT
Stages with AJCC TNM and molecular prognostic groups, selects biomarker-matched therapy from NCCN guidelines, assesses response with RECIST 1.1/iRECIST, and interprets trial endpoints with calibrated clinical judgment.
| Version | Commit | First seen |
|---|---|---|
| 1.0.0latest | 9127e2358430 |